Intellectia LogoIntellectia
Product
Resources
Markets
News
Partner Program
Pricing
Log inTry for Free
Intellectia Logo
Log in
Intellectia Logo

Product

Features
Financial AI Agent
Stock Technical Analysis
Stock Monitor
Hedge Fund Tracker
AI Screener
Trading Strategies
AI Stock Picker
Swing Trading
Quant AI
Stock Chart Patterns
Daytrading Center
AI Earnings Prediction
Whales Auto Tracker
Backtesting Playground

Resources

Learn
Blog
Earnings
Tutorial
Help Center
Company
About Us
Contact
Press
Reward Program
Partner Program
Tools
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Compare
TradingView
SeekingAlpha

Markets

Trending Stocks
Hot Crypto
Trending News
All Stocks

News

Trading News
Overview
Top News
Daily Market Brief
Earnings
Latest
Newswire
Stock News
Crypto News
Monitor News
Partner ProgramPricing
Start for Free
  1. Home
    2. >
  2. Stock
    3. >
  3. PRPH
stocks logo

PRPH

-
collectAdd to Watchlistadvanced chartAdvanced Chart
$
0.000
0(0.000%)1D
collectadvanced chart
    Overview
    Forecast
    Valuation
    Earnings
High
--
Open
--
VWAP
--
Vol
--
Mkt Cap
--
Low
--
Amount
--
EV/EBITDA(TTM)
--
Total Shares
--
EV
--
EV/OCF(TTM)
--
P/S(TTM)
--
Intellectia AI SwingMax
Intellectia AI SwingMax

Market Estimates

Earnings Estimates
Earnings Estimates
Revenue
YoY Chg
EPS
YoYChg
FY2025Q2
FY2025Q3
FY2025Q4
3.55M
+43.49%
--
--
5.69M
+80.86%
--
--
9.67M
+294.05%
--
--
Estimates Revision
The market is revising No Change the revenue expectations for ProPhase Labs, Inc. (PRPH) for FY2025, with the revenue forecasts being adjusted by 0% over the past three months. During the same period, the stock price has changed by -60.55%.
Revenue Estimates for FY2025
No Change
down Image
0.00%
In Past 3 Month
EPS Estimates for FY2025
No Change
down Image
0.00%
In Past 3 Month
Stock Price
Go Down
down Image
-60.55%
In Past 3 Month

Valuation Metrics

The current forward P/E ratio for Prophase Labs Inc (PRPH.O) is 0.00, compared to its 5-year average forward P/E of -7.38. For a more detailed relative valuation and DCF analysis to assess Prophase Labs Inc 's fair value, click here.
  • Forward PE
  • Forward EV/EBITDA
  • Forward PS

Forward PE

The forward P/E ratio is a valuation metric that divides a company's current stock price by its estimated future earnings per share over the next 12 months.
StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
N/A
5Y Average PE
-7.38
Current PE
0.00
Overvalued PE
116.84
Undervalued PE
-131.60

Forward EV/EBITDA

The forward EV/EBITDA ratio is a valuation metric that divides a company's enterprise value (EV) by its estimated future earnings before interest, taxes, depreciation, and amortization (EBITDA) over the next 12 months.
StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
N/A
5Y Average EV/EBITDA
1.47
Current EV/EBITDA
0.00
Overvalued EV/EBITDA
23.61
Undervalued EV/EBITDA
-20.68

Forward PS

The forward P/S ratio is a valuation metric that divides a company's current stock price by its estimated future sales (or revenue) per share over the next 12 months.
StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
N/A
5Y Average PS
1.76
Current PS
0.00
Overvalued PS
3.06
Undervalued PS
0.46
Financial AI Agent
Financial AI Agent

Financials

Annual
Quarterly
N/A
Total Revenue
N/A
Operating Profit
N/A
Net Income after Tax
N/A
EPS - Diluted
N/A
Free Cash Flow
N/A
Gross Profit Margin - %
N/A
FCF Margin - %
N/A
Net Margin - %
N/A
ROIC

Trading Trends

  • Insider
  • Hedge Fund
  • Congress Trading
Insider
Insiders are Neutral. There are no significant trading trends over the last month.
Sold
Bought
Hedge Fund
Hedge Funds are Neutral. There are no significant trading trends over the last quarter.
Sold
Bought
Congress Trading
Congress are Neutral. There are no significant trading trends over the last month.
Sold
Bought
Insider
Insiders are Neutral. There are no significant trading trends over the last month.
Sold
Bought
AI Stock Picker
AI Stock Picker

PRPH News & Events

Events Timeline

(ET)
2025-11-26
17:36:39
ALT5 Sigma Corporation appoints Steven Plumb as Chief Financial Officer
select
2025-10-29 (ET)
2025-10-29
08:36:40
ProPhase Labs reveals the release of BE-Smart study on Esophageal Cancer
select
2025-10-28 (ET)
2025-10-28
08:19:57
ProPhase Labs appoints RedChip to spearhead investor relations initiatives
select
Sign Up For More Events
Sign Up For More Events

News

[object Object]
Preview
2.0
12-01Benzinga
Vision Marine Technologies Stock Rises Over 10%; Check Out 20 Stocks Making Moves in Premarket Trading

  • Vision Marine Technologies Performance: Vision Marine Technologies Inc. shares rose 10.5% to $1.36 in pre-market trading after announcing strong financial results for the fiscal year ending August 31, 2025, and highlighting strategic expansion following the acquisition of Nautical Ventures, which generated $12.8 million in revenue.

  • Other Gainers in Pre-Market Trading: Several stocks saw significant gains in pre-market trading, including WEBUY Global Ltd. (+62.1%), Direct Digital Holdings, Inc. (+60.6%), and INVO Fertility, Inc. (+24.7%), with various companies announcing acquisitions or strategic plans.

  • Notable Losers in Pre-Market Trading: SMX (Security Matters) PLC experienced a sharp decline of 24.6% after a previous surge, while Springview Holdings Ltd. fell 20.7% following a reverse share split announcement.

  • Market Overview: The pre-market trading session showed a mix of gains and losses across various stocks, with some companies like New Fortress Energy Inc. and Canadian Solar Inc. also reporting notable increases.

[object Object]
Preview
5.0
11-26Globenewswire
ProPhase Labs Invites Investors to Webinar on December 1, 2025
  • Patent Approval: ProPhase Labs recently achieved full U.S. patent approval for its BE-Smart™ Esophageal Cancer Test, targeting a market size of up to $14 billion, marking a significant breakthrough in early cancer detection.
  • Strategic Partnership: The company's collaboration with Crown Medical Collections aims to recover over $50 million in COVID-19 receivables, which will significantly improve cash flow and financial health.
  • Product Line Expansion: ProPhase plans to commercialize the BE-Smart™ test and expand its DNA Complete® and DNA Expand™ product lines, which are expected to unlock substantial shareholder value and drive company growth.
  • Market Potential: ProPhase's consumer genomics business, Nebula Genomics, houses one of the world's largest and most diverse DNA datasets, further enhancing its competitive position in the genomics and consumer health sectors.
[object Object]
Preview
8.5
10-22SeekingAlpha
ProPhase Labs Seeks Approval to Offer 226.31 Million Shares of Common Stock to Shareholders
  • ProPhase Labs Stock Offering: ProPhase Labs has filed to sell 226.31 million shares of common stock for its holders.
  • Financial Information: Additional financial details regarding ProPhase Labs are available, indicating the company's current market activities.
Sign Up For More News

People Also Watch

FAQ

arrow icon

What is Prophase Labs Inc (PRPH) stock price today?

The current price of PRPH is 0.14 USD — it has increased 3.7 % in the last trading day.

arrow icon

What is Prophase Labs Inc (PRPH)'s business?

ProPhase Labs, Inc. is a biotech, genomics, and consumer products company. The Company is engaged in providing whole genome sequencing solutions, diagnostic development, such as its potentially life-saving test for the early detection of esophageal cancer and a direct-to-consumer marketing platform for OTC dietary supplements. It develops, manufactures, and commercializes health and wellness solutions. Its Diagnostic services segment provides diagnostic information services to a range of customers in the United States, including health plans, third-party payers and government organizations. Its Consumer products segment is engaged in the research, development, manufacture, distribution, marketing and sale of OTC consumer healthcare products and dietary supplements in the United States and provides personal genomics products and services. The Company also develops and markets dietary supplements under the TK Supplement brand, which includes Legendz XL and Triple Edge XL.

arrow icon

What is the price predicton of PRPH Stock?

Wall Street analysts forecast PRPH stock price to fall over the next 12 months. According to Wall Street analysts, the average 1-year price target for PRPH is  USD with a low forecast of USD and a high forecast of USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.

arrow icon

What is Prophase Labs Inc (PRPH)'s revenue for the last quarter?

Prophase Labs Inc revenue for the last quarter amounts to 883.00K USD, decreased -37.64 % YoY.

arrow icon

What is Prophase Labs Inc (PRPH)'s earnings per share (EPS) for the last quarter?

Prophase Labs Inc. EPS for the last quarter amounts to -0.16 USD, decreased -54.29 % YoY.

arrow icon

What changes have occurred in the market's expectations for Prophase Labs Inc (PRPH)'s fundamentals?

The market is revising No Change the revenue expectations for ProPhase Labs, Inc. (PRPH) for FY2025, with the revenue forecasts being adjusted by 0% over the past three months. During the same period, the stock price has changed by -60.55%.
arrow icon

How many employees does Prophase Labs Inc (PRPH). have?

Prophase Labs Inc (PRPH) has 96 emplpoyees as of December 05 2025.

arrow icon

What is Prophase Labs Inc (PRPH) market cap?

Today PRPH has the market capitalization of 6.25M USD.

Intellectia LogoIntellectiaIntellectia LogoIntellectia

Redefine Your Investment Decisions

TwitterTwitterYoutubeYoutubeQuoraQuoraDiscordDiscordLinkedinLinkedinTelegramTelegram
AppStoreGooglePlay

Copyright © 2025 Intellectia.AI. All Rights Reserved.

pci certified logo
Company
HomeContactAbout UsNews Release
Compare
TradingViewSeeking Alpha
Features
Financial AI AgentStock Technical AnalysisStock MonitorHedge Fund TrackerAI ScreenerDaytrading Center
Strategies
AI Stock PickerSwing TradingStock Chart PatternsEarnings TradingDaytrading CenterAI Earnings PredictionQuant AIWhales Auto TrackerBacktesting Playground
Free Tools
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Resource
BlogTutorialEarningsTrending StocksCrypto MarketPartner ProgramTerms of UsePrivacy PolicySecuritySitemap
Start for Free